HCW9218
2 papers5 findings
- 2 independent labs in 3 countries
- Funders: National Cancer Institute and 4 more
- Humans1
- Animals1
Outcomes
5Lung development
upin mice1
1 study
Lung development
upin mice1
HCW9218 improves lung development in mice.
“Treatment with HCW9218 prevented senescent cell accumulation and rescued lung development in the hyperoxia mouse model.”
Animalshyperoxia modellung
bioRxiv (Cold Spring Harbor Laboratory)Sep 4, 2025Preprint
Senescent cells
downin mice1
1 study
Senescent cells
downin mice1
HCW9218 decreases senescent cells in mice.
“Treatment with HCW9218 prevented senescent cell accumulation and rescued lung development in the hyperoxia mouse model.”
Animalshyperoxia modellung
bioRxiv (Cold Spring Harbor Laboratory)Sep 4, 2025Preprint
Physical function
upin mice1
1 study
Physical function
upin mice1
HCW9218 improves physical function in mice.
“Long-term survival studies also showed that HCW9218 treatment improved physical performance without compromising the health span of naturally aged mice.”
Animalsnaturally aged mice
Aging cellMar 26, 2023
Insulin resistance
upin mice1
1 study
Insulin resistance
upin mice1
HCW9218 improves insulin resistance in mice.
“subcutaneous administration of HCW9218 reduced senescent islet β cells and SASP resulting in improved glucose tolerance, insulin resistance, and aging index”
Animalsdiabetic db/db mouse model
Aging cellMar 26, 2023
Cellular senescence
downin mice1
1 study
Cellular senescence
downin mice1
HCW9218 decreases cellular senescence in mice.
“subcutaneous administration of HCW9218 reduced senescent islet β cells and SASP resulting in improved glucose tolerance, insulin resistance, and aging index”
Animalsdiabetic db/db mouse model
Aging cellMar 26, 2023
Latest
bioRxiv
Natural killer cell TGF-β signaling regulates senolytic activity and vascular patterning in the postnatal lung
Preprint: study in peopleLung